We are driven by our conviction that genomics should be available to the many, not the few
Genomics has the power to save lives and vastly improve the human condition. Realizing the potential of the genome to exponentially improve the human condition requires continued innovation and the democratization of genomics.
To accelerate access to genomics, we are:
Deliver innovation and affordability
99.9%
reduction in sequencing cost over 16 years
Enable catalytic philanthropy
$120 million
committed to genomic testing for low- and middle-income geographies through iHope Genetic Health
Catalyze genomic startups to broaden the genomic ecosystem
$1.1 billion
raised in venture capital funding by 74 startups since the inception of Illumina Accelerator
Increase genomic data diversity
+8
commercial and philanthropic efforts supported to increase diversity in human genetics
Expand reach with payer coverage, genomic literacy, and patient advocacy
1.2 billion
lives covered for genomic testing
Drive Innovation and Affordability
Since 2001, the cost of DNA sequencing has dropped more than 100,000x from $100 million per human genome to ~ $200* with the NovaSeq X sequencers, putting our dream of a $100 genome within reach
There is an urgency to our mission because we understand that today’s discoveries have the potential to help tomorrow’s patients and address some of the world’s most pressing challenges. Every technological breakthrough that reduces cost, improves throughput, decreases turnaround time, or improves ease of use helps us realize our potential, improving more lives and protecting our planet.*
*~$200 / genome based on US list price, assuming 120 Gb/genome; compared to NovaSeq 6000
Through the iHope Genetic Health Program, we have committed $120 million to reach patients in low-and middle-income communities
Challenges like inequity of access to health care and underrepresentation of global data diversity magnify the need to bring the power of genomics to all. We work to close the genomic medicine gap and advance the next generation of care in geographies where specialists are limited, and clinical resources are sparse.
Through our partnership with Genetic Alliance, iHope Genetic Health aims to provide clinical whole-genome sequencing (WGS) access to tens of thousands of families across the globe impacted by genetic disease. At least half of iHope Genetic Health's efforts focus on areas of the world in need outside the US, with more than one-third of Illumina support dedicated to patients in Africa.
Learn moreThe larger our network of partners, the more patients' lives we can help change
1 billion
2021
2 billion
2026 goal
People Covered by Genomic Testing
We are building a global community of students, scientists, researchers, educators, entrepreneurs, policy-makers, and clinicians passionate about using genomics to transform human health.
As an engine of genomics innovation, we understand that the larger we grow our network of partners, the more patient lives we can help change. Together, we are expanding the reach of genomics by catalyzing genomic startups, expanding genomic literacy, advocating for greater genomic coverage and adoption, and empowering patients.
To date, our Illumina for Startups initiatives have raised $1.1 billion in collective venture capital funding to accelerate innovation in the entrepreneurial community. We are aiming to reach over 200 organizations by 2030.
Learn moreFighting pandemics with genomics
Genomics for good in action
Championing Cancer Patients Through More Knowledge
Building Pathogen Surveillance Capabilities in Africa
